Insulin Sensitizing Pharmacotherapy for Prevention of Myocardial Infarction in Patients With Diabetes Mellitus
Authors:
- Anne R. CappolaACAnne R. Cappola
- Jesse A. BerlinJBJesse A. Berlin
- Stephen E. KimmelSKStephen E. Kimmel
- 1 March 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (5) , 651-654
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous interventionThe American Journal of Cardiology, 2004
- The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirinJACC, 2004
- Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromesAmerican Heart Journal, 2004
- Reappraisal of the pharmacologic approach to treatment of type 2 diabetes mellitusThe American Journal of Cardiology, 2002
- Nonhypoglycemic Effects of ThiazolidinedionesAnnals of Internal Medicine, 2001
- Antidiabetic Drugs Present and FutureDrugs, 2000
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Type 2 diabetes care: the role of insulin-sensitizing agents and practical implications for cardiovascular disease preventionThe American Journal of Medicine, 1998
- Insulin Sensitivity and AtherosclerosisCirculation, 1996
- Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart DiseaseNew England Journal of Medicine, 1996